For instance, CB1R has been shown to be upregulated in podocytes, mesangial cells, and RPTCs in diabetes, and its pharmacological inhibition by CB1R antagonists ameliorates diabetes-induced kidney dysfunction, inflammation, and fibrosis17–25. The gene discussed is CNR1; the disease is diabetes mellitus.